Citation Impact
Citing Papers
Vaccine Immunity to Pathogenic Fungi Overcomes the Requirement for CD4 Help in Exogenous Antigen Presentation to CD8+ T Cells
2003
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients
2007 StandoutNobel
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
POORLY ENCAPSULATED CRYPTOCOCCUS NEOFORMANS FROM PATIENTS WITH AIDS. I: PRELIMINARY OBSERVATIONS
1986
POORLY ENCAPSULATED CRYPTOCOCCUS NEOFORMANS FROM PATIENTS WITH AIDS. II. CORRELATION OF CAPSULE SIZE OBSERVED DIRECTLY IN CEREBROSPINAL FLUID WITH THAT AFTER ANIMAL PASSAGE
1986
Immunity to fungi
1990
IL-13 Induces Disease-Promoting Type 2 Cytokines, Alternatively Activated Macrophages and Allergic Inflammation during Pulmonary Infection of Mice with Cryptococcus neoformans
2007
CCR5 Dictates the Equilibrium of Proinflammatory IL-17+ and Regulatory Foxp3+ T Cells in Fungal Infection
2010
β-Arrestin-dependent Constitutive Internalization of the Human Chemokine Decoy Receptor D6
2004 StandoutNobel
Spontaneous and Cationic Lipid-Mediated Uptake of Antisense Oligonucleotides in Human Monocytes and Lymphocytes
1998
A Toll-like receptor recognizes bacterial DNA
2000 StandoutNature
Interactions of fungi with phagocytes
2002
Functional equivalence of cryptococcal and haptene-specific T suppressor factor (TsF)
1991
Cooperative Stimulation of Dendritic Cells by Cryptococcus neoformans Mannoproteins and CpG Oligodeoxynucleotides
2008
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
2010 Standout
Role of the Capsule in Phagocytosis of Cryptococcus neoformans
1988
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
The T cell response against fungal infections
1997
Functional Overlap between eIF4G Isoforms in Saccharomyces cerevisiae
2010 StandoutNobel
Chemokine Receptor 2 (CCR2) in Atherosclerosis, Infectious Diseases, and Regulation of T‐Cell Polarization
2003
Evolutionary Convergence on Highly-Conserved 3′ Intron Structures in Intron-Poor Eukaryotes and Insights into the Ancestral Eukaryotic Genome
2008
Induced humoral immunity and vaccination against major human fungal pathogens
2002
Leukocyte recruitment during pulmonary Cryptococcus neoformans infection
2000
Chemokines in the systemic organization of immunity
2003
Regulation of T Helper Cell Differentiation In Vivo by GP43 from Paracoccidioides brasiliensis Provided by Different Antigen‐Presenting Cells
2003
Regulatory T Cells and Immune Tolerance
2008 StandoutNobel
Antibodies Elicited by a Cryptococcus neoformans-Tetanus Toxoid Conjugate Vaccine Have the Same Specificity as Those Elicited in Infection
1992
CR3 (CD11b/CD18) and CR4 (CD11c/CD18) Are Involved in Complement-Independent Antibody-Mediated Phagocytosis of Cryptococcus neoformans
2002
Low Diversity Cryptococcus neoformans Variety grubii Multilocus Sequence Types from Thailand Are Consistent with an Ancestral African Origin
2011
Brucellosis
2005 Standout
Isolation and characterization of capsule structure mutant strains of Cryptococcus neoformans
2002
PI3K signaling of autophagy is required for starvation tolerance and virulenceof Cryptococcus neoformans
2008 StandoutNobel
CRYPTOCOCCAL INFECTION AND TH1-TH2 CYTOKINE BALANCE
2002
Fungi, dendritic cells and receptors: a host perspective of fungal virulence
2002
Antibody to Cryptococcus neoformans capsular glucuronoxylomannan promotes expression of interleukin‐12Rβ2 subunit on human T cells in vitro through effects mediated by antigen‐presenting cells
2002
A systems biology approach to the mutual interaction between yeast and the immune system
2010
Biology of Natural Killer Cells
1989 Standout
Fungal stealth technology
2007
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
Glucocorticoids and invasive fungal infections
2003
Functional Diversity of Chemokines and Chemokine Receptors in Response to Viral Infection of the Central Nervous System
2006
Killing of Cryptococcus neoformans by Human Peripheral Blood Mononuclear Cells Stimulated in Culture
1991
The worm has turned – microbial virulence modeled in Caenorhabditis elegans
2005
Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12
2001
Echinocandin antifungal drugs
2003 Standout
A CLC‐type chloride channel gene is required for laccase activity and virulence in Cryptococcus neoformans
2003
Overview of Host Defenses in Fungal Infections
1992
Genetic control of the humoral response to cryptococcal capsular polysaccharide in mice
1988
CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells
2000
Robust Th1 and Th17 Immunity Supports Pulmonary Clearance but Cannot Prevent Systemic Dissemination of Highly Virulent Cryptococcus neoformans H99
2009
The contribution of melanin to microbial pathogenesis
2003
Activation-Induced Cytidine Deaminase Expression in CD4+ T Cells is Associated with a Unique IL-10-Producing Subset that Increases with Age
2011 StandoutNobel
Innate and adaptive determinants of host susceptibility to medically important fungi
2003
Fungal Recognition by TLR2 and Dectin-1
2007
New use of BCG for recombinant vaccines
1991 StandoutNature
CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice
2003
CpG DNA and LPS induce distinct patterns of activation in human monocytes
1999
Phagocytosis—The mighty weapon of the silent warriors
2002
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Influence of Cryptococcal Antigens on Cell-Mediated Immunity
1988
Fungal vaccines: real progress from real challenges
2008
Immunity to Candida albicans: Th1, Th2 cells and beyond
1999
Immunity to fungal infections
2011 Standout
Emerging fungal threats to animal, plant and ecosystem health
2012 StandoutNature
Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro.
1993
Exploring the full spectrum of macrophage activation
2008 Standout
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Direct Cleavage of eIF4G by Poliovirus 2A Protease Is Inefficientin Vitro
1998
Alternative activation of macrophages
2003 Standout
Functional equivalence of cryptococcal and haptene-specific T suppressor factor (TsF)
1991
Pathogen Recognition and Innate Immunity
2006 Standout
The j-Subunit of Human Translation Initiation Factor eIF3 Is Required for the Stable Binding of eIF3 and Its Subcomplexes to 40 S Ribosomal Subunits in Vitro
2004 StandoutNobel
Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cells
2001
The Many Roles of Chemokines and Chemokine Receptors in Inflammation
2006 Standout
Antioxidant systems in the pathogenic fungi of man and their role in virulence
1999
Intracellular parasitism of macrophages by Cryptococcus neoformans
2001
Role for C5 and Neutrophils in the Pulmonary Intravascular Clearance of Circulating Cryptococcus neoformans
1993
Eukaryotic Translation Initiation Factor 4G Is Targeted for Proteolytic Cleavage by Caspase 3 during Inhibition of Translation in Apoptotic Cells
1998
Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism.
1994
Minimap2: pairwise alignment for nucleotide sequences
2018 Standout
Pathogenesis of Cryptococcus neoformans in congenitally immunodeficient beige athymic mice
1990
Soluble Polysaccharides of Cryptococcus neoformans
1988
Costimulation via Glucocorticoid-Induced TNF Receptor in Both Conventional and CD25+ Regulatory CD4+ T Cells
2004 StandoutNobel
Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans
1993
IL-23 Enhances the Inflammatory Cell Response in Cryptococcus neoformans Infection and Induces a Cytokine Pattern Distinct from IL-12
2006
Biological Correlates of Capsular (Quellung) Reactions ofCryptococcus neoformans
2000
Lack of CCR2 Results in Increased Mortality and Impaired Leukocyte Activation and Trafficking Following Infection of the Central Nervous System with a Neurotropic Coronavirus
2001
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Cryptococcal capsular polysaccharide-induced modulation of murine immune responses
1982
Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans
1988
The glucuronoxylomannan of Cryptococcus neoformans serotype A is a type 2 T-cell-independent antigen
1992
Expression and Characterization of the Chemokine Receptors CCR2 and CCR5 in Mice
2001
CD8+ T lymphocytes in intracellular microbial infections
1988
Induction of Tumor Immunity by Removing CD25+CD4+ T Cells: A Common Basis Between Tumor Immunity and Autoimmunity
1999 StandoutNobel
Cutaneous cryptococcosis in athymic and beige-athymic mice
1991
Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice
1994
The CD8+ Dendritic Cell Subset Selectively Endocytoses Dying Cells in Culture and In Vivo
2002 StandoutNobel
Galactoxylomannans of Cryptococcus neoformans
1992
The SQV-1 UDP-glucuronic acid decarboxylase and the SQV-7 nucleotide-sugar transporter may act in the Golgi apparatus to affect Caenorhabditis elegans vulval morphogenesis and embryonic development
2002 StandoutNobel
CNLAC1Is Required for Extrapulmonary Dissemination ofCryptococcus neoformansbut Not Pulmonary Persistence
2004
Copper Active Sites in Biology
2014 Standout
Genetic resistance to murine cryptococcosis: the beige mutation (Chédiak-Higashi syndrome) in mice
1985
Virulence factors of medically important fungi
1996
Effects of cyclosporine in experimental cryptococcal meningitis
1985
CD4+ T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract.
1992
Polysaccharide antigens of the capsule of Cryptococcus neoformans
1994
Comparison of the PREMIER cryptococcal antigen enzyme immunoassay and the latex agglutination assay for detection of cryptococcal antigens
1991
Functional cloning and characterization of a UDP- glucuronic acid decarboxylase: The pathogenic fungus Cryptococcus neoformans elucidates UDP-xylose synthesis
2001
Induction of Interleukin-12 and Gamma Interferon Requires Tumor Necrosis Factor Alpha for Protective T1-Cell-Mediated Immunity to PulmonaryCryptococcus neoformansInfection
2002
Role of IgG and complement component C5 in the initial course of experimental cryptococcosis.
1989
Toll-Like Receptor 4 Mediates Intracellular Signaling Without TNF-α Release in Response to Cryptococcus neoformans Polysaccharide Capsule
2001
The Capsule ofCryptococcus neoformansReduces T-Lymphocyte Proliferation by Reducing Phagocytosis, Which Can Be Restored with Anticapsular Antibody
1999
Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells.
1991
Strain variation in composition and molecular size of the capsular polysaccharide of Cryptococcus neoformans serotype A
1986
Colonization and pathogenesis of Cryptococcus neoformans in gnotobiotic mice
1987
Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans
1982
CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.
1996 Standout
Purification of the 115-kilodalton exoantigen of Cryptococcus neoformans and its recognition by immune sera
1993
Production and function of cytokines in natural and acquired immunity to Candida albicans infection
1995
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
2000 Standout
Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat
1994
Multiple virulence factors of Cryptococcus neoformans are dependent on VPH1
2001
CCR2 Expression Determines T1 Versus T2 Polarization During Pulmonary Cryptococcus neoformans Infection
2000
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells.
1991
Cryptococcus neoformansIs a Facultative Intracellular Pathogen in Murine Pulmonary Infection
2000
Activation of the complement system by pathogenic fungi
1996
CpG Motifs in Bacterial DNA and Their Immune Effects
2002 Standout
Killing ofCryptococcus neoformansby rat alveolar macrophages
1989
Role of the Mannose Receptor in a Murine Model ofCryptococcus neoformansInfection
2008
Endogenous interleukin-12 is involved in resistance to Brucella abortus infection
1995
Accelerated decay of C3b to iC3b when C3b is bound to the Cryptococcus neoformans capsule
1993
Interleukin-12 in infectious diseases
1997
Activation and Differentiation of Autoreactive B-1 Cells by Interleukin 10 Induce Autoimmune Hemolytic Anemia in Fas-deficient Antierythrocyte Immunoglobulin Transgenic Mice
2002 StandoutNobel
Occurrences, specificities, and functions of ubiquitous antibodies in human serum that are reactive with the Cryptococcus neoformans cell wall
1994
CSF-1–Dependent Red Pulp Macrophages Regulate CD4 T Cell Responses
2011 StandoutNobel
Tuberculosis: Commentary on a Reemergent Killer
1992 StandoutScience
Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide.
1985
Catecholamine Oxidative Products, but Not Melanin, Are Produced byCryptococcus neoformansduring Neuropathogenesis in Mice
1999
Macrophages in resistance to candidiasis
1997
Absence of Macrophage Inflammatory Protein-1α Prevents the Development of Blinding Herpes Stromal Keratitis
1998 StandoutNobel
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Synergistic Antifungal Activities of Bafilomycin A 1 , Fluconazole, and the Pneumocandin MK-0991/Caspofungin Acetate (L-743,873) with Calcineurin Inhibitors FK506 and L-685,818 against Cryptococcus neoformans
2000
Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses toCryptococcus neoformans
2001
Identification of simple arylfluorosulfates as potent agents against resistant bacteria
2021 StandoutNobel
The Danger Model: A Renewed Sense of Self
2002 StandoutScience
Genetic resistance to murine cryptococcosis: increased susceptibility in the CBA/N XID mutant strain of mice
1985
Inflammatory Responses to Cryptococcosis in Congenitally Athymic Mice
1991
Discovery and Development of Small-Molecule Chemokine Coreceptor CCR5 Antagonists
2006
Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection.
1993
Immunobiology of Dendritic Cells
2000 Standout
Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B
1994
Expression of CXC Chemokine Ligand 10 from the Mouse Hepatitis Virus Genome Results in Protection from Viral-Induced Neurological and Liver Disease
2007 StandoutNobel
Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody
1990
Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans
1994
Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A
1989
CD8 T Cell-Mediated Killing ofCryptococcus neoformansRequires Granulysin and Is Dependent on CD4 T Cells and IL-15
2002
CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells
1999
Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants
1986
Multilocus enzyme typing of Cryptococcus neoformans
1993
Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans
1991
Natural Killer Cell Activity and Macrophage-Dependent Inhibition of Growth or Killing of Mycobacterium avium Complex in a Mouse Model
1990
Regulation of Cryptococcal Capsular Polysaccharide by Iron
1993
Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells
2000
Interplay between Protective and Inhibitory Antibodies Dictates the Outcome of Experimentally Disseminated Candidiasis in Recipients of aCandida albicansVaccine
2002
Optimal T Cell Responses to Cryptococcus neoformans Mannoprotein Are Dependent on Recognition of Conjugated Carbohydrates by Mannose Receptors
2002
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity
1991
Alloantigen-enhanced accumulation of CCR5+‘effector’ regulatory T cells in the gravid uterus
2006
Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines
1990
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
Primary Dendritic Cells PhagocytoseCryptococcus neoformansvia Mannose Receptors and Fcγ Receptor II for Presentation to T Lymphocytes
2002
Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody
1987
Mycobacterium aviumComplex Infection in the Acquired Immunodeficiency Syndrome
1991 Standout
Long-lasting, specific immunologic unresponsiveness associated with cryptococcal meningitis.
1982
Killing of Cryptococcus neoformans strains by human neutrophils and monocytes
1991
Prospects for the development of fungal vaccines
1997
Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo
2000
Resistance to challenge and macrophage activity in mice previously vaccinated with formalin-killed Cryptococcus neoformans
1984
Importance of Interleukin-10 in Genetic Susceptibility of Mice toCoccidioides immitis
1998
T-cell-dependent and T-cell-independent mechanisms of tolerance to glucuronoxylomannan of Cryptococcus neoformans serotype A
1993
Works of J W Murphy being referenced
K562 Cell Strains Differ in Their Response to Poliovirus Infection
1995
Direct antimicrobial activity of T cells
1995
Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils.
1996
Direct interactions of human lymphocytes with the yeast-like organism, Cryptococcus neoformans.
1993
Kinetics of cellular infiltration and cytokine production during the efferent phase of a delayed‐type hypersensitivity reaction
1997
Specific Suppression of Human Tumor Necrosis Factor-α Synthesis by Antisense Oligodeoxynucleotides
1996
MECHANISMS OF NATURAL RESISTANCE TO HUMAN PATHOGENIC FUNGI
1991
Cryptococcal Immunity and Immunostimulation
1992
T Cell Response To Soluble Cryptococcal Antigens After Recovery From Cryptococcal Infection
1989
What Makes Cryptococcus neoformans a Pathogen?
1998
Natural Killer Cells and Cryptococcus Neoformans
1993
Pathogenesis of Cryptococcus neoformans is Associated with Quantitative Differences in Multiple Virulence Factors
1999
Role of Interleukin-4 in Resistance to Cryptococcus neoformans Infection
2003
Cryptococcal polysaccharides bind to CD18 on human neutrophils
1997
Murine natural killer cells are fungicidal to Cryptococcus neoformans
1991
Differences in Components at Delayed-Type Hypersensitivity Reaction Sites in Mice Immunized with Either a Protective or a Nonprotective Immunogen ofCryptococcus neoformans
2002
In vitro interactions of immune lymphocytes and Cryptococcus neoformans
1982
Host-Etiological Agent Interactions in Intranasally and Intraperitoneally Induced Cryptococcosis in Mice
1980
Effects of Tumor Necrosis Factor Alpha on Dendritic Cell Accumulation in Lymph Nodes Draining the Immunization Site and the Impact on the Anticryptococcal Cell-Mediated Immune Response
2002
Pathogenesis I: interactions of host cells and fungi
2000
Cutting Edge: Role of C-C Chemokine Receptor 5 in Organ-Specific and Innate Immunity toCryptococcus neoformans
1999
Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen
1993
Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens
1988
Responses of murine natural killer cells to binding of the fungal target Cryptococcus neoformans
1991
Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha production
1997
Cytoplasmic Components of Natural Killer Cells Limit the Growth of Cryptococcus neoformans
1990
Capsule size of Cryptococcus neoformans: control and relationship to virulence
1977
Differential Regulation of Immune Responses by Highly and Weakly VirulentCryptococcus neoformansIsolates
1999
Dendritic Cells in the Induction of Protective and Nonprotective Anticryptococcal Cell-Mediated Immune Responses
2000
Induction of antigen-specific suppression by circulating Cryptococcus neoformans antigen.
1988
Characterization of a cell population which amplifies the anticryptococcal delayed-type hypersensitivity response
1990
Natural cellular resistance of beige mice against Cryptococcus neoformans.
1986
Response of Congenitally Athymic (Nude) and Phenotypically Normal Mice to Cryptococcus neoformans Infection
1979
Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen.
1982
Correlation of natural killer cell activity and clearance of Cryptococcus neoformans from mice after adoptive transfer of splenic nylon wool-nonadherent cells
1986
CTLA-4 Down-Regulates the Protective Anticryptococcal Cell-Mediated Immune Response
2000
Immunoadsorption of Cryptococcus-specific suppressor T-cell factors
1986
Cryptococcal culture filtrate antigen for detection of delayed-type hypersensitivity in cryptococcosis
1979
In vitro effects of natural killer cells against Paracoccidioides brasiliensis yeast phase
1984
Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans
1991
Effects of the two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion
1995
Regulation of cell-mediated immunity in cryptococcosis. III. Characterization of second-order T suppressor cells (Ts2).
1985
Type 1 and type 2 cytokines: from basic science to fungal infections.
1998
Antigen-Induced Protective and Nonprotective Cell-Mediated Immune Components againstCryptococcus neoformans
1998
Antibody-dependent natural killer cell-mediated growth inhibition of Cryptococcus neoformans
1986
Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response
1993
Regulation of cell-mediated immunity in cryptococcosis. II. Characterization of first-order T suppressor cells (Ts1) and induction of second-order suppressor cells.
1983
In vitro binding of natural killer cells to Cryptococcus neoformans targets
1985
Murine natural killer cell interactions with a fungal target, Cryptococcus neoformans
1989
Clearance of Cryptococcus neoformans from immunologically suppressed mice
1989
In vitro reactivity of natural killer (NK) cells against Cryptococcus neoformans.
1982
MIP-1α contributes to the anticryptococcal delayed-type hypersensitivity reaction and protection against Cryptococcus neoformans
1997
Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute?
1998
Immunological down‐regulation of host defenses in fungal infections
1999
The Cryptococcus neoformans Gene DHA1 Encodes an Antigen That Elicits a Delayed-Type Hypersensitivity Reaction in Immune Mice
2000
Regulation of cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response
1994
Immunological Unresponsiveness Induced by Cryptococcal Capsular Polysaccharide Assayed by the Hemolytic Plaque Technique
1972
Introns and Splicing Elements of Five Diverse Fungi
2004
Effects of cyclosporin A on the cells responsible for the anticryptococcal cell-mediated immune response and its regulation
1989
Induction and expression of cell-mediated immune responses in inbred mice infected with Coccidioides immitis
1988
Characterization of a third-order suppressor T cell (Ts3) induced by cryptococcal antigen(s)
1987
Effects of first-order Cryptococcus-specific T-suppressor cells on induction of cells responsible for delayed-type hypersensitivity
1985